Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Autoimmune Diseases × Pyridostigmine Bromide × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Myasthenia Gravis 2 Strabismus 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Emergence Delirium 1 Autoimmune Diseases 1

Interventions

telitacicept 1 Valsartan 1 Pyridostigmine Bromide 1 Prednisone 1 Infliximab 1 Hydroxychloroquine 1 Etanercept 1 Adalimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06723548 2024-12-09

Telitacicept and Low-dose Steroids in Refractory Myasthenia Gravis

First Affiliated Hospital of Wenzhou Medical University

Phase 4 Not yet recruiting

Autoimmune Diseases, Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡